Core Viewpoint - Shareholders Tianjin Sequoia and Beijing Sequoia plan to reduce their holdings in Yirui Technology by no more than 2% due to personal funding needs, marking the second reduction plan in the past year [2][3][5]. Summary by Sections Shareholder Reduction Plan - Tianjin Sequoia and Beijing Sequoia intend to reduce a total of up to 4,004,367 shares, representing 2% of Yirui Technology's total share capital, through block trading from August 15 to November 14, 2025 [3][6]. - The shares to be reduced are from the capital reserve converted into share capital before and after the IPO, with the reason cited as personal funding needs [3][6]. Previous Reduction Activities - In the previous year, from September 30 to November 1, 2024, Tianjin Sequoia and Beijing Sequoia reduced a total of 2,855,772 shares at prices ranging from 113.42 to 123.03 yuan per share, realizing approximately 3.24 billion to 3.51 billion yuan [9][10]. Current Shareholding Status - As of now, Tianjin Sequoia holds 11,785,900 shares (5.89% of total shares), while Beijing Sequoia holds 5,547,300 shares (2.77% of total shares) [10]. Financial Performance - Yirui Technology's net profit has been declining, with figures of 6.41 billion yuan in 2022, 6.07 billion yuan in 2023, and 4.65 billion yuan in 2024. The net profit after deducting non-recurring gains and losses was 5.17 billion yuan, 5.91 billion yuan, and 4.39 billion yuan for the same years [12][13]. - In the first quarter of 2025, the net profit attributable to shareholders was 1.43 billion yuan, a year-on-year increase of 2.74%, while the net profit after deducting non-recurring gains and losses decreased by 9.19% [14][15]. Market Conditions - The industry in which Yirui Technology operates is experiencing weak downstream demand, and the company's product gross margin is sensitive to changes in selling prices and product structure. A decline in downstream demand or increased industry competition could lead to a decrease in product prices [17].

Group 1 - The company has restructured its receivables by accepting properties worth 221.699 million yuan to offset receivables and unpaid project payments totaling 98.1263 million yuan, along with an additional cash payment of 123.5727 million yuan [1] - The restructuring indicates that the company is dealing with debts from real estate firms that are unable to repay, opting for property as a form of debt settlement [1] - The company has expanded its business scope to include real estate leasing, indicating a strategic shift towards becoming a landlord [2][3] Group 2 - The company plans to add housing leasing and non-residential real estate leasing to its operational scope based on its business development needs [3] - Other companies mentioned include Zhongzhuang and Yirui Technology, with various financial activities such as bond adjustments and shareholder transactions [4]

重要内容提示： 截至本公告披露日，奕瑞电子科技集团股份有限公司（以下简称"公司"、"奕 瑞科技"）股东天津红杉聚业股权投资合伙企业（有限合伙）（以下简称"天津红 杉"）、北京红杉信远股权投资中心（有限合伙）（以下简称"北京红杉"）分别持 有公司股份 11,785,883 股、5,547,286 股，分别占公司总股本的 5.89%、2.77%。 上述股份均为公司 IPO 前及上市后权益分派资本公积转增股本取得的股份，该部 分股份已于 2021 年 9 月 22 日、2023 年 4 月 24 日、2024 年 6 月 17 日、2025 年 ? 减持计划的主要内容 ? 本次减持股东持股的基本情况 证券代码：688301 证券简称：奕瑞科技 公告编号：2025-049 转债代码：118025 转债简称：奕瑞转债 奕瑞电子科技集团股份有限公司 关于公司股东减持股份计划的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 公司股东天津红杉、北京红杉拟通过大宗交易的方式减持其所持有的公司 股份合计不超过 4,004,3 ...

重要内容提示： 本次减持股东持股的基本情况 | 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-049 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 关于公司股东减持股份计划的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 截至本公告披露日，奕瑞电子科技集团股份有限公司（以下简称"公司"、"奕 瑞科技"）股东天津红杉聚业股权投资合伙企业（有限合伙）（以下简称"天津红 杉"）、北京红杉信远股权投资中心（有限合伙）（以下简称"北京红杉"）分别持 有公司股份 11,785,883 股、5,547,286 股，分别占公司总股本的 5.89%、2.77%。 上述股份均为公司 IPO 前及上市后权益分派资本公积转增股本取得的股份，该部 分股份已于 2021 年 9 月 22 日、2023 年 4 月 24 日、2024 年 6 月 17 日、2025 年 6 月 19 日上市流通。 | | 董事、监事和高级 ...

Core Viewpoint - The announcement from Yirui Technology indicates that shareholders Tianjin Sequoia and Beijing Sequoia plan to reduce their holdings through block trading, which may impact the stock's liquidity and market perception [1] Shareholder Holdings - Tianjin Sequoia holds 11.7859 million shares, representing 5.89% of the total share capital [1] - Beijing Sequoia holds 5.5473 million shares, representing 2.77% of the total share capital [1] Planned Share Reduction - The shareholders intend to reduce their holdings by up to 4.0044 million shares, which is not more than 2% of the total shares outstanding [1] - The reduction period is set from August 15, 2025, to November 14, 2025 [1] Previous Share Reduction - The two shareholders previously reduced their holdings by 2% (2.8558 million shares) between September 30, 2024, and November 1, 2024 [1] - The reduction price range for the previous transaction was between 113.42 and 123.03 yuan per share [1]

Core Points - The company has received approval from the China Securities Regulatory Commission (CSRC) for the issuance of A-shares to specific investors [1] - The approval is valid for 12 months from the date of registration [1] - The company is required to adhere to the submitted documents and issuance plan during the stock issuance process [1] Summary by Sections - **Approval Details** - The CSRC has issued a document approving the company's application for stock issuance to specific investors [1] - The approval mandates strict compliance with the submitted application documents and issuance plan [1] - **Regulatory Compliance** - The company must report any significant events to the Shanghai Stock Exchange from the date of approval until the completion of the issuance [1] - **Board Responsibilities** - The company's board will handle the issuance matters within the stipulated timeframe and fulfill information disclosure obligations [2]

| 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-048 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 关于 2024 年度向特定对象发行 A 股股票申请 获得中国证券监督管理委员会同意注册批复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 奕瑞电子科技集团股份有限公司（以下简称"公司"）于近日收到中国证券 监督管理委员会出具的《关于同意上海奕瑞光电子科技股份有限公司向特定对象 发行股票注册的批复》（证监许可〔2025〕1495 号）（以下简称"批复文件"），批 复文件内容如下： 一、同意你公司向特定对象发行股票的注册申请。 二、你公司本次发行应严格按照报送上海证券交易所的申报文件和发行方案 实施。 三、本批复自同意注册之日起 12 个月内有效。 四、自同意注册之日起至本次发行结束前，你公司如发生重大事项，应及时 报告上海证券交易所并按有关规定处理。 公司董事会将按照上述批复文件和相关法律法规的要求以及 ...

Company Overview - Yirui Technology's closing price on July 11 was 88.55 yuan, down 1.01%, with a rolling PE ratio of 37.80 times and a total market value of 17.729 billion yuan [1] - The company ranks 77th in the medical device industry, which has an average PE ratio of 52.06 times and a median of 37.22 times [1] - As of the first quarter of 2025, 47 institutions held shares in Yirui Technology, including 39 funds, with a total holding of 82.5452 million shares valued at 9.443 billion yuan [1] Business Operations - Yirui Technology focuses on the research, production, sales, and service of digital X-ray detectors, high-voltage generators, combination ray sources, and tubes [1] - The main product lines include the universal series, dental series, mammography series, radiotherapy series, industrial series, high-voltage generators, and combination ray sources [1] Financial Performance - In the first quarter of 2025, Yirui Technology reported revenue of 482 million yuan, a year-on-year decrease of 1.92%, while net profit was 143 million yuan, an increase of 2.74% [1] - The sales gross margin for the company was 48.92% [1]

Investment Rating - The report maintains a "Buy" rating for the company [6][20]. Core Views - The company is a leading global supplier of X-ray core components and solutions, with a diversified downstream distribution. The recovery in downstream medical, dental, and industrial sectors since 2025 is promising, and new products like CT tubes and silicon-based OLED microdisplay backplanes are expected to have significant growth potential [1][2]. - The company has announced an investment of up to RMB 1.8 billion for a silicon-based OLED microdisplay backplane production project, which is anticipated to add a capacity of 5,000 units per month [3][15]. - There is substantial domestic replacement potential for core components like CT tubes, with an estimated market space of RMB 1 to 5 billion due to the ongoing anti-dumping investigations against imports from the US and India [4][20]. Summary by Sections Financial Performance - The company expects a revenue decline of 2% in 2024, primarily due to poor downstream conditions, but anticipates a recovery in 2025 with a projected revenue increase of 17.18% [2][10]. - The forecasted net profit for 2025-2027 is RMB 5.9 billion, RMB 8.5 billion, and RMB 11.0 billion, representing year-on-year growth rates of 26%, 46%, and 29% respectively [5][19]. Revenue Breakdown - The detector segment is expected to grow at rates of 16%, 19%, and 19% from 2025 to 2027, with a recovery in demand from the medical and dental sectors [12][17]. - The core components segment is projected to see revenue growth of 43%, 39%, and 28% over the same period, driven by advancements in high-voltage generators and ray sources [13][17]. - The solutions and technical services segment is anticipated to grow significantly, with expected revenues of RMB 350 million, RMB 500 million, and RMB 700 million from 2025 to 2027 [14][17]. Valuation - The target price for the company is set at RMB 132, based on a price-to-earnings (PE) ratio of 45 times for 2025, reflecting a significant adjustment from previous estimates due to overall market conditions [5][20]. - The company's market capitalization is approximately RMB 17.36 billion, with a closing price of RMB 86.70 as of July 2, 2025 [7][10].

Group 1 - The core viewpoint of the news is that Yirui Technology's stock performance and financial metrics indicate a stable position within the medical device industry, despite a slight decline in revenue [1] - As of July 1, Yirui Technology's closing price was 88.5 yuan, with a PE ratio of 37.78 times and a total market capitalization of 17.719 billion yuan [1] - The average PE ratio for the medical device industry is 51.70 times, with a median of 37.36 times, positioning Yirui Technology at the 77th rank within the industry [1][2] Group 2 - Yirui Technology reported a revenue of 482 million yuan for Q1 2025, reflecting a year-on-year decrease of 1.92%, while net profit was 143 million yuan, showing a year-on-year increase of 2.74% [1] - The company's gross profit margin stands at 48.92% [1] - As of March 31, 2025, Yirui Technology had 5,745 shareholders, a decrease of 883 from the previous count, with an average holding value of 352,800 yuan per shareholder [1]